Catalyst Wire Dossier Catalyst Wire Dossier

Remazolam Methyl Benzene Sulfonic Acid for Injection

Remazolam · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remazolam Methyl Benzene Sulfonic Acid for Injection, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

See pricing